Nicola Wealth Management LTD. Has $6.26 Million Stock Position in Perrigo Company plc $PRGO

Nicola Wealth Management LTD. raised its stake in Perrigo Company plc (NYSE:PRGO) by 38.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 281,000 shares of the company’s stock after purchasing an additional 78,000 shares during the period. Nicola Wealth Management LTD. owned 0.20% of Perrigo worth $6,257,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in PRGO. Geneos Wealth Management Inc. raised its stake in Perrigo by 439.1% during the 1st quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock worth $27,000 after buying an additional 786 shares during the period. Huntington National Bank lifted its stake in shares of Perrigo by 237.8% in the second quarter. Huntington National Bank now owns 1,054 shares of the company’s stock valued at $28,000 after buying an additional 742 shares in the last quarter. Hantz Financial Services Inc. boosted its stake in shares of Perrigo by 101.0% in the 2nd quarter. Hantz Financial Services Inc. now owns 1,234 shares of the company’s stock worth $33,000 after buying an additional 620 shares during the last quarter. Kestra Investment Management LLC grew its stake in shares of Perrigo by 57.1% during the 2nd quarter. Kestra Investment Management LLC now owns 1,766 shares of the company’s stock worth $47,000 after acquiring an additional 642 shares during the period. Finally, Blue Trust Inc. lifted its position in shares of Perrigo by 35.2% during the second quarter. Blue Trust Inc. now owns 3,542 shares of the company’s stock worth $95,000 after acquiring an additional 923 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on PRGO shares. Canaccord Genuity Group reduced their target price on Perrigo from $40.00 to $20.00 and set a “buy” rating on the stock in a research note on Thursday, November 6th. Wall Street Zen downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Jefferies Financial Group cut their price target on shares of Perrigo from $27.00 to $23.00 and set a “hold” rating on the stock in a report on Monday, October 27th. Weiss Ratings restated a “sell (d+)” rating on shares of Perrigo in a research note on Monday, December 22nd. Finally, Zacks Research lowered shares of Perrigo from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th. One research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and a consensus price target of $20.33.

Perrigo Trading Down 2.1%

Shares of PRGO opened at $14.41 on Tuesday. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.51 and a quick ratio of 1.44. The firm has a market cap of $1.98 billion, a P/E ratio of -37.92, a price-to-earnings-growth ratio of 1.32 and a beta of 0.40. The company has a 50 day simple moving average of $13.86 and a two-hundred day simple moving average of $19.42. Perrigo Company plc has a 1 year low of $12.17 and a 1 year high of $30.93.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.05. Perrigo had a positive return on equity of 9.16% and a negative net margin of 1.21%.The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same period last year, the company earned $0.81 EPS. The company’s revenue for the quarter was down 4.1% on a year-over-year basis. Perrigo has set its FY 2025 guidance at 2.700-2.80 EPS. On average, equities analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Stockholders of record on Friday, November 28th were issued a $0.29 dividend. The ex-dividend date was Friday, November 28th. This represents a $1.16 annualized dividend and a dividend yield of 8.0%. Perrigo’s payout ratio is currently -305.26%.

Insiders Place Their Bets

In other Perrigo news, Director Geoffrey M. Parker bought 7,500 shares of Perrigo stock in a transaction that occurred on Wednesday, November 12th. The shares were bought at an average cost of $14.18 per share, with a total value of $106,350.00. Following the transaction, the director directly owned 17,375 shares of the company’s stock, valued at approximately $246,377.50. This represents a 75.95% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.40% of the stock is currently owned by insiders.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.